Affiliation:
1. Department of Veterinary Microbiology, Division of Veterinary Medicine, Walter Reed Army Institute of Research, Washington, D.C. 20012
Abstract
Reported high activity of rifampin for
Pseudomonas pseudomallei
could not be verified by extensive in vitro tests conducted with 31 recently isolated strains. Minimal inhibitory concentrations of rifampin were 25 μg/ml for three strains and greater than 25 μg/ml for 28 strains. Rifampin had relatively poor in vitro activity when compared with tetracycline drugs and chloramphenicol antibiotics now commonly used for treating melioidosis.
Publisher
American Society for Microbiology
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference10 articles.
1. Treatment of melioidosis. 1;Cooper E. B.;Amer. Med. Ass.,1968
2. Pseudomonas pseudomallei: susceptibility to chemotherapeutic agents;Eickhoff T. C.;J. Infec. Dis.,1970
3. Susceptibility in vitro and in vivo of Pseudomonas pseudomallei to rifampin and tetracyclines;Fisher M. W.;Appl. Microbiol.,1971
4. Afebrile cases of melioidosis;Green R.;Brit. Med. J.,1949
5. The control of experimental infection in mice produced by Pseudomonas pseudomallei;Hobby G. L.;Amer. Rev. Resp. Dis.,1969